Sunday, November 17, 2024

Latest:

Why comprehensive metrics matter in patient outcome studies
Raising awareness about pancreatic cancer: A message from Dr. William E. Fisher
Brain stars hold our memories
Adult allergies: Q&A with Dr. David Corry
Quitting smoking: tips for lung cancer awareness month

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

MYCN

From The Labs

Researchers identify an Achilles’ heel in neuroblastoma

August 16, 2022 cancer treatment, FATP2, fatty acid metabolism, metabolimics, MYCN, neuroblastoma, Research

A metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.

From The Labs

Turning the molecular clock back on halts neuroblastoma tumor growth

July 27, 2021 BMAL1, brain cancer, molecular clock, MYCN, neuroblastoma, Research, RORa

Restoring function of the molecular clock blocks tumor growth in advanced neuroblastoma and can make tumors more sensitive to conventional chemotherapy.

From the Labs: Aging signs.